The Epidemiology of Antimicrobial Resistant Bacteria in the Pediatric Population (CE Session)

4.69 (35 votes)


Date/Time: April 10, 2024 | 2:25 - 3:00 pm ET

While antibiotic resistant bacteria have existed for millions of years and pose an increasing global health threat to all populations, it’s only recently that there has been increased recognition of drug-resistant infection trends in infants and children. During this session, the presenter will give an overview of the current landscape of AMR infections in pediatric populations, cover the common multidrug-resistant organisms (MDROs) leading to infections, and discuss how to manage them.  

Learning Objectives: 

At the end of this session, the learner should be able to:

  • Describe the landscape of antimicrobial-resistant infections in the pediatric population; 
  • Review common antimicrobial-resistant organisms leading to infections in the pediatric population; 
  • Explain the management of antimicrobial-resistant infections in the pediatric population. 

Target Audience: 

Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.

Rachel Medernach, MD, MSCI

Assistant Professor

Rush University Medical Center

Rachel Medernach, MD, MSCI, is currently an assistant professor in the Division of Infectious Diseases in the Department of Medicine at Rush University Medical Center. Dr. Medernach completed her undergraduate studies at Loyola University Chicago, majoring in psychology and minoring in biology and chemistry. She then attended medical school at Loyola University Chicago’s Stritch School of Medicine, followed by a residency at Rush University Medical Center in Internal Medicine/Pediatrics where she studied Gram-negative pathogens in the pediatric population. Finally, Dr. Medernach completed an infectious diseases fellowship at Northwestern University with a laboratory focusing on the development of resistance mechanisms in Gram-negative pathogens. She also obtained her Masters of Science in Clinical Investigation during this time.

Components visible upon registration.